American Society of Hematology, Blood Advances, 19(1), p. 1473-1477, 2017
DOI: 10.1182/bloodadvances.2017006734
Full text: Download
Key Points Intragenic PAX5 amplification defines a novel, relapse-prone subtype of B-cell precursor acute lymphoblastic leukemia with a poor outcome.